Connection

Mark Hamann to Methicillin-Resistant Staphylococcus aureus

This is a "connection" page, showing publications Mark Hamann has written about Methicillin-Resistant Staphylococcus aureus.
  1. Methicillin-resistant Staphylococcus aureus (MRSA)-active metabolites from Platanus occidentalis (American Sycamore). J Nat Prod. 2009 Dec; 72(12):2141-4.
    View in: PubMed
    Score: 0.321
  2. The anti-MRSA compound 3-O-alpha-L-(2?,3?-di-p-coumaroyl)rhamnoside (KCR) inhibits protein synthesis in Staphylococcus aureus. J Proteomics. 2020 01 06; 210:103539.
    View in: PubMed
    Score: 0.159
  3. HPLC Plasma Assay of a Novel Anti-MRSA Compound, Kaempferol-3-O-Alpha-L-(2",3"-di-p-coumaroyl)rhamnoside, from Sycamore Leaves. Nat Prod Commun. 2015 Aug; 10(8):1383-6.
    View in: PubMed
    Score: 0.119
  4. Evaluation of three medicinal plant extracts against Plasmodium falciparum and selected microganisms. Afr J Tradit Complement Altern Med. 2014; 11(4):142-6.
    View in: PubMed
    Score: 0.110
  5. Antimicrobial metabolites from the Paracel Islands sponge Agelas mauritiana. J Nat Prod. 2012 Apr 27; 75(4):774-8.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.